Delving into the Latest Updates on Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd. with Synapse

Overview

主要目的：评估ICP-105胶囊在实体瘤受试者中的安全性和耐受性、通过剂量递增试验确定推荐后续研究用药剂量次要目的： 1.评价口服ICP-105胶囊在实体瘤受试者中单次给药和连续给药的药代动力学特征 2.评价食物对口服ICP-105胶囊的药代动力学的影响

[Translation]

Primary objectives: To evaluate the safety and tolerability of ICP-105 capsules in subjects with solid tumors and determine the recommended subsequent study dose through a dose escalation study Secondary objectives: 1. To evaluate the pharmacokinetic characteristics of single and continuous administration of oral ICP-105 capsules in subjects with solid tumors 2. To evaluate the effect of food on the pharmacokinetics of oral ICP-105 capsules

Start Date31 Aug 2018

Sponsor / Collaborator

Beijing Tiancheng Pharmaceutical Technology Co Ltd

[+1]

100 Clinical Results associated with Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Nanjing Tianyin Jianhua Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data